Suzanne Cheng

4.6k citations
67 papers · 3.7k · 1 hit paper · h-index 34

Impact in

  • Genetics top 5%
    • Genetic Associations and Epidemiology
    • Hemoglobinopathies and Related Disorders
    • Melanoma and MAPK Pathways
    • Peroxisome Proliferator-Activated Receptors

Papers in

    • Genetic Associations and Epidemiology 16
    • Hemoglobinopathies and Related Disorders 3
    • Melanoma and MAPK Pathways 4
    • Peroxisome Proliferator-Activated Receptors 3
    • DNA Repair Mechanisms 2
    • Molecular Biology Techniques and Applications 2

Suzanne Cheng

66 papers receiving 3.5k citations

Suzanne Cheng's Hit Papers

Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study 2014 · 839 citations
8390+4+8Years since publication250500750

Peers

Suzanne Cheng
Comparison fields: 5 of 91
  • Genetics 182
  • Molecular Biology 800
  • Genetics 367
  • Periodontics 73
  • Oncology 176
Replace Takashi Minami with:
Takashi Minami Japan
Siddhartha Kar United Kingdom
Stefano Martinotti Italy
Kazuya Yamada Japan
Akira Ishisaki Japan
Mitsuhide Noshiro Japan
Yasushi Daikuhara Japan
Robert D. Koos United States
Xiaotian Chang China
Homayoun Vaziri Canada
Suzanne Cheng relative to Takashi Minami Japan Takashi Minami's profile →
Citations per field
00.5×2×4×5.8×
Takashi Minami · 1×
Citations per year

Countries citing papers authored by Suzanne Cheng

Since Specialization
Citations

This map shows the geographic impact of Suzanne Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Cheng more than expected).

Fields of papers citing papers by Suzanne Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Cheng. The network helps show where Suzanne Cheng may publish in the future.

Co-authors

The 25 scholars most cited alongside Suzanne Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Cheng Line = papers co-authored together Suzanne Cheng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
Hit paper breakdown →
2014839
2 1994165
3 1994149
4 2003142
5 2012131
6 2012103
7 200695
8 200391
9 200582
10 200578
11 200777
12 200970
13 200569
14 200663
15 200261
16 200660
17 200757
18 200456
19 200054
20 200554

About Suzanne Cheng

Suzanne Cheng is a scholar working on Genetics, Molecular Biology, Genetics, Cardiology and Cardiovascular Medicine and Hematology, having authored 67 papers that have together received 3.7k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (16 papers), Melanoma and MAPK Pathways (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Hemoglobinopathies and Related Disorders (3 papers), DNA Repair Mechanisms (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Genetics (182 citations), Molecular Biology (800 citations), Genetics (367 citations), Periodontics (73 citations) and Oncology (176 citations). Suzanne Cheng has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Robert Y.L. Zee, Paul M. Ridker, Mark Stoneking, Russell Higuchi, Lori L. Steiner, Sheng-Yung P. Chang, Klaus Lindpaintner, Patti E. Gravitt, Richard Respess and Edward J. Lammer. Their work appears in journals such as Stroke, Clinical Chemistry and Laboratory Medicine (CCLM), European Journal of Human Genetics, Clinical Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact